Mindray Unveils the Premium Ultrasound System Resona A20 at EUROSON 2024

Mindray launched the premium ultrasound system Resona A20 at EUROSON 2024. Powered by Acoustic Intelligence Technology (AIT), Resona A20 represents a significant leap forward in ultrasound imaging capabilities: it uses further improved diagnostic imaging technology to enable innovative clinical research as it provides a new level of insights into tissue structure, blood flow perfusion, and biological characteristics.

The new AFM transducer technology
In ultrasound, seeing the subtle depends largely on the transducer. Resona A20 comes with AFM transducers, a new generation of transducer technology that covers a wide range of clinical applications and brings excellent imaging performance for whole body imaging. AFM transducer technology includes three major technologies: Acoustic Boost Technology, Free Band Technology and Matrix Thin Slice.

If you look at the future of ultrasound, one of the keywords is Artificial intelligence (AI). Resona A20 provides a wide range of AI tools such as Smart Breast, Smart Thyroid and Automated Liver STE which facilitate the daily workflow and makes it more accurate and efficient.

Pushing the boundaries of ultrasound technology
Super-Resolution Contrast-Enhanced Ultrasound (SR CEUS) imaging reveals the intricated microcirculation details at the micron level. This provides a gamechanger in detection and treatment of different oncology cases, for example, liver tumors.

This is where Resona A20 comes in, as Prof. Ernst Michael Jung, Head of the Ultrasound Center at University Hospital Regensburg, Germany, underlines: “Today, using the A20 technology with new super-resolution CEUS we can find liver tumors of less than five millimeters. By detecting tumors with less than 10 millimeters we can use this technology during treatment, e.g. for ablation therapies. This will probably change the way we look at surgery in the future.”




Early disease detection with confidence
Resona A20 also provides multi-parametric liver solutions for chronic liver disease assessments. Especially for steatosis, liver inflammation or fibrosis, we have comprehensive, intuitive and reproducible tools for non-invasive quantitative analysis.

And among one of them, Visco-elastography is an innovative tool for tissue viscosity assessments. Resona A20 STVi provides dual quantitative parameters, the dispersion and viscosity coefficient for more comprehensive study of the property. This novel application has been extended to liver and breast tumors which is opening a new era for these applications.

M Reference is a multi-parametric imaging and analysis tool, for chronic liver disease and breast tumor assessments. It provides up to 5 parameters assessments. For example, the shear wave elastography, visco-elastography and attenuation imaging, all of them included.

By combining cutting-edge technology with insights from leading medical professionals, the Resona A20 not only enhances current diagnostic capabilities but also opens new avenues for clinical research and treatment. This revolutionary system emphasizes Mindray’s commitment to pushing the boundaries of medical imaging.